Anxiety Drug Recalled Due To Risk Of Overdose
All 60-mgm tablets of prescription drug pms-Phenobarbital used for treating seizure, anxiety and sleep disorders have been recalled, after Health Canada found over-sized tablets of the drug in the Canadian market.
Containing more Phenobarbital than indicated on the label, the tablets pose an accidental overdose hazard that can prove life-threatening. As well, according to Health Canada, those taking a higher-than-recommended overdose, also run the risk of falling into a coma or experiencing cardiac arrest.
Used to treat anxiety, sleep disorders and seizures, symptoms of a possible pms-Phenobarbital overdose may include: " Uncontrolled eye movements. " Lack of muscle co-ordination. " Impaired speech. " Extreme drowsiness. " Decreased breathing and heart rate.
If, you are experiencing any of the above symptoms, you are advised to immediately contact emergency services, while all consumers who have already used the drug, should contact a doctor and return the product to their pharmacist for a replacement.
Consumers must not stop their medication without consulting a health-care professional, as abrupt discontinuation can cause withdrawal symptoms, which include irritability, headache, dizziness, sweating, tremors, nausea, vomiting, abdominal cramps, weight loss or anorexia, nightmares or insomnia, and if used for treating seizures, can result in an increase in seizures.
The Canadian distributor, Pharmascience Inc. of Montreal, is recalling all lots on the market, though so far, there have been no reports of adverse reactions associated with consumption of the drug.
Consumers seeking more information can contact Health Canada at (613) 957-2991 or toll-free at 1-866-225-0709.
- Login or register to post comments
Print
Email to friend
Related Articles
- Probiotic Tablets Containing Traces Of Milk Protein Recalled
- Consumers Warned To Stop Taking Hydroxycut Diet Supplements
- Depression, Anxiety Linked To Weight Gain
- New Stomach And Heartburn Drug Gets FDA Approval
- Heart Drug Digoxin Recalled by Caraco Pharma
- Health Canada Probes Potential Link Between Diabetes Drug And Cancer
- Generic Manufacturer Recalls Product
- FDA Approves Tamiflu For Children Under One-Year
Kathleen Sebelius, Secretary of Health and Human Services said Tuesday immediate benefits will be visible to consumers via increased insurer...
As the lawmakers clashed fiercely Tuesday, political manoeuvring in the Capitol saw Democrats struggling to defend procedural shortcuts in order...
The coalition seeking to challenge the city ordinance regarding marijuana that would limit the number of stores selling marijuana at 70, has...
Michelle Obama’s cover story for next week’s Newsweek magazine i. e. 22nd March shows the First Lady with an apple and which is titled ‘Feed Your...
The debate continues unabated in USA over whether vaccines could cause autism in children.
Even though a court ruled last week there wasn’t...
According to researchers from an American university, BanLec, the lectin found in bananas could prove to be a powerful weapon in the fight against...
According to two new studies, since the 1990s non-melanoma skin cancer incidences have been rising making it the commonest cancer form, affecting...
According to the results of a preliminary study, salsalate, a common pain reliever may help type 2 diabetics control their blood sugar levels,...
Researchers say some people who are deficient in vitamin D can reduce their risk of hearth disease by 30% by raising the amount of vitamin D in...
According to US cosmetic surgeons, instead of using collagen, using muscle from your neck for a lip graft, makes for the perfect plump pout.
...Michel Sidibe, the head of UN AIDS agency – UNAIDS said Monday, since homosexuals, drug users and prostitutes are criminalized by the law, new HIV...
Crime-scene drama fans may soon find fingerprint dusting to be passé, after a new forensic technique debuts on their favourite TV series i. e....












